Utah's medical marijuana market continued to grow in April, with sales reaching nearly $17 million and the number of active patients climbing above 113,000, according to the state's latest monthly report. The report, released, shows Utah had 113,202 patients with active medical cannabis cards as of the end of April. That's up from 112,093 at the end of March, an increase of 1,109 patients in one month.
The program also includes 1,016 registered recommending medical providers, 916 processor and cultivator agents, 955 pharmacy agents, 443 courier agents and 95 pharmacy medical providers.
Patient demographics remained largely unchanged from March. Those ages 31 to 40 make up the largest share of patients at 26.09%, followed by those 41 to 50 at 22.34% and those 21 to 30 at 22%. Patients ages 51 to 65 account for 18.42%, while those 65 and older make up 11.07%.
Persistent pain continues to account for the overwhelming majority of qualifying conditions, with 98,684 patients listing it. PTSD was next at 5,613 patients, followed by nausea at 2,433, cancer at 2,091, autism at 770, MS at 724, epilepsy at 721 and Crohn's disease at 573. Sales also rose in April. Medical marijuana purchases totaled $16,911,700 for the month, up from $16,259,200 in March. When added to the nearly $50 million sold during the first three months of the year, Utah's 2026 medical marijuana sales now total roughly $67 million.
Read more at The Marijuana Herald
